These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 39117091
1. Thymic epithelial tumor medical treatment: A narrative review. Huang Q, Zhu L, Liu Y, Zhang Y. Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189167. PubMed ID: 39117091 [Abstract] [Full Text] [Related]
2. [Chinese guideline for clinical diagnosis and treatment of thymic epithelial tumors (2021 Edition)]. Multidisciplinary Committee of Oncology, Chinese Physicians Association. Zhonghua Zhong Liu Za Zhi; 2021 Apr 23; 43(4):395-404. PubMed ID: 33902202 [Abstract] [Full Text] [Related]
3. Evolving treatment landscape in thymic epithelial tumors: From mechanism to therapy. Yang Y, Yu Y, Fan Y, Li H. Biochim Biophys Acta Rev Cancer; 2024 Sep 23; 1879(5):189145. PubMed ID: 38942215 [Abstract] [Full Text] [Related]
4. Understanding the landscape of immunotherapy in thymic epithelial tumors. Maniar R, Loehrer PJ. Cancer; 2023 Apr 15; 129(8):1162-1172. PubMed ID: 36808725 [Abstract] [Full Text] [Related]
5. Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors. Tateo V, Manuzzi L, De Giglio A, Parisi C, Lamberti G, Campana D, Pantaleo MA. Int J Mol Sci; 2020 Nov 28; 21(23):. PubMed ID: 33260538 [Abstract] [Full Text] [Related]
6. Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor. Jing X, Zhu H, Li Y, Jia W, Zhai X, Li J, Yu J. Immunotherapy; 2022 Oct 28; 14(14):1097-1107. PubMed ID: 36093721 [Abstract] [Full Text] [Related]
7. Thymoma and thymic carcinoma in children and adolescents: a report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT). Stachowicz-Stencel T, Orbach D, Brecht I, Schneider D, Bien E, Synakiewicz A, Rod J, Ferrari A, Cecchetto G, Bisogno G. Eur J Cancer; 2015 Nov 28; 51(16):2444-52. PubMed ID: 26259494 [Abstract] [Full Text] [Related]
9. Thymic epithelial tumor treatment in Japan: analysis of hospital cancer registry and insurance claims data, 2012-2014. Kanemura H, Tamura T, Nishimura N, Kobayashi D, Higashi T. Jpn J Clin Oncol; 2020 Mar 09; 50(3):310-317. PubMed ID: 31829410 [Abstract] [Full Text] [Related]
10. Expression of PD-1 and PD-L1 in thymic epithelial neoplasms. Weissferdt A, Fujimoto J, Kalhor N, Rodriguez J, Bassett R, Wistuba II, Moran CA. Mod Pathol; 2017 Jun 09; 30(6):826-833. PubMed ID: 28281549 [Abstract] [Full Text] [Related]
11. Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma. Wang Y, Nie J, Dai L, Hu W, Chen X, Han J, Ma X, Tian G, Han S, Long J, Zhang Z, Fang J. Thorac Cancer; 2019 Jan 09; 10(1):17-23. PubMed ID: 30411854 [Abstract] [Full Text] [Related]
14. Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis. Remon J, Villacampa G, Facchinetti F, Di Maio M, Marcuse F, Tiseo M, Hochstenbag M, Hendriks LEL, Besse B. Eur J Cancer; 2023 Feb 09; 180():117-124. PubMed ID: 36592506 [Abstract] [Full Text] [Related]
15. Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Clinical Practice Guideline. Falkson CB, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E. J Thorac Oncol; 2022 Nov 09; 17(11):1258-1275. PubMed ID: 36031176 [Abstract] [Full Text] [Related]
16. An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors. Agrafiotis AC, Berzenji L, Koyen S, Vermeulen D, Winthagen R, Hendriks JMH, Van Schil PE. Int J Mol Sci; 2023 Dec 02; 24(23):. PubMed ID: 38069386 [Abstract] [Full Text] [Related]